chartexchange

EVO
Evotec SE
stockNASDAQADR

At CloseNov 18, 2026 3:59:30 PM EST
1.46USD-1.351%(-0.02)35,797
After-hoursNov 18, 2026 4:00:30 PM EST
1.46USD0.000%(0.00)
Loading…
Loading…
518.87M
Healthcare
Drug Manufacturers-Specialty & Generic
HQ
Hamburg, Hamburg, Germany
Previous Close
$1.48
Beta
1.14
52-Week High
$3.87 2026-01-13
52-Week Low
$1.33 2026-10-13
SMA 50
$1.58
SMA 200
$2.40
Avg. Vol 10D
79,920
Avg. Vol 30D
84,051
Avg. Vol 90D
98,683
Relative Vol
0.43
355.39M
336.82M
5.1300%
2,960
EVO Profile

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.

EVO Performance
PeriodPriceDateChangeBeta
1W1.692026-11-11-13.61%-1.127
1M1.422026-10-19+2.82%-0.492
3M1.912026-08-18-23.56%-0.261
6M2.742026-05-18-46.72%0.432
1Y2.962025-11-18-50.68%1.142
2Y5.552024-11-18-73.69%—
5Y24.072021-11-18-93.93%1.109
EVO Stock Summary

Evotec SE (NASDAQ:EVO) stock price today is $1.46, and today's volume is 35,797. EVO is down 1.351% today. The 30 day average volume is 84,051. EVO market cap is $518.87M with 355.39M shares outstanding.